HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension.

AbstractBACKGROUND:
Right ventricular (RV) failure is the main prognostic factor in pulmonary hypertension, and ventricular capillary density (CD) has been reported to be a marker of RV maladaptive remodeling and failure. Our aim was to determine whether right intracoronary endothelial progenitor cell (EPC) infusion can improve RV function and CD in a piglet model of chronic thromboembolic pulmonary hypertension (CTEPH).
METHODS:
We compared 3 groups: sham (n = 5), CTEPH (n = 6), and CTEPH with EPC infusion (CTEPH+EPC; n = 5). After EPC isolation from CTEPH+EPC piglet peripheral blood samples at 3 weeks, the CTEPH and sham groups underwent right intracoronary infusion of saline, and the CTEPH+EPC group received EPCs at 6 weeks. RV function, pulmonary hemodynamics, and myocardial morphometry were investigated in the animals at 10 weeks.
RESULTS:
After EPC administration, the RV fractional area change increased from 32.75% (interquartile range [IQR], 29.5%-36.5%) to 39% (IQR, 37.25%-46.50%; P = .030). The CTEPH+EPC piglets had reduced cardiomyocyte surface areas (from 298.3 μm2 [IQR, 277.4-335.3 μm2] to 234.6 μm2 (IQR, 211.1-264.7 μm2; P = .017), and increased CD31 expression (from 3.12 [IQR, 1.27-5.09] to 7.14 [IQR, 5.56-8.41; P = .017). EPCs were found in the RV free wall at 4 and 24 hours after injection but not 4 weeks later.
CONCLUSIONS:
Intracoronary infusion of EPC improved RV function and CD in a piglet model of CTEPH. This novel cell-based therapy might represent a promising RV-targeted treatment in patients with pulmonary hypertension.
AuthorsFanny Loisel, Bastien Provost, Julien Guihaire, David Boulate, Nassim Arouche, Myriam Amsallem, Jennifer Arthur-Ataam, Benoît Decante, Peter Dorfmüller, Elie Fadel, Georges Uzan, Olaf Mercier
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 157 Issue 2 Pg. 655-666.e7 (02 2019) ISSN: 1097-685X [Electronic] United States
PMID30669226 (Publication Type: Journal Article, Video-Audio Media)
CopyrightCopyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Topics
  • Animals
  • Animals, Newborn
  • Arterial Pressure
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Progenitor Cells (transplantation)
  • Neovascularization, Physiologic
  • Pulmonary Arterial Hypertension (etiology, physiopathology, surgery)
  • Pulmonary Embolism (complications, physiopathology)
  • Recovery of Function
  • Stem Cell Transplantation
  • Sus scrofa
  • Time Factors
  • Transplantation, Autologous
  • Ventricular Dysfunction, Right (etiology, physiopathology, prevention & control)
  • Ventricular Function, Right
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: